Revolution Medicines (RVMD) EBT Margin (2019 - 2023)
Revolution Medicines (RVMD) posted quarterly EBT Margin of 21724.26% for Q4 2023, down 2135485.0% year-over-year from N/an in Q4 2022, and down 745.12% quarter-over-quarter from 2570.55% in Q2 2023.
Revolution Medicines (RVMD) EBT Margin (2019 - 2023) Analysis & Trends
Revolution Medicines' EBT Margin history runs 5 years deep, the most recent figure standing at 21724.26% for Q4 2023.
- In Q4 2023, EBT Margin fell 2135485.0% year-over-year to 21724.26%; the TTM figure through Sep 2024 stood at 76377.09% (down 7509565.0% YoY), while the FY2023 annual figure was 3798.71%, down 309457.0% from the prior year.
- EBT Margin for Q4 2023 stood at 21724.26%, down from 2570.55% in the prior quarter.
- The five-year high for EBT Margin was 76.95% in Q1 2019, with the low at 21724.26% in Q4 2023.
- The 5-year median for EBT Margin is 386.72% (2020), against an average of 1945.8%.
- The sharpest annual moves came in 2022 and 2023: EBT Margin surged 261449 bps in 2022, then tumbled 2135485 bps in 2023.
- Revolution Medicines' EBT Margin stood at 156.92% in 2019, then plunged by 146 bps to 386.72% in 2020, then plunged by 44 bps to 556.83% in 2021, then soared by 34 bps to 369.41% in 2022, then slumped by 5781 bps to 21724.26% in 2023.
- Business Quant data shows RVMD's EBT Margin at 21724.26% in Q4 2023, 2570.55% in Q2 2023, and 970.89% in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 41.75% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 35.61% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 34.77% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 18.33% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -94.22% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 12.09% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.77% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -2.67% |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -20,427.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -21,724.26% |
| Jun 30, 2023 | -2,570.55% |
| Mar 31, 2023 | -970.89% |
| Dec 31, 2022 | -369.41% |
| Sep 30, 2022 | -2,193.86% |
| Jun 30, 2022 | -671.59% |
| Mar 31, 2022 | -760.72% |
| Dec 31, 2021 | -556.83% |
| Sep 30, 2021 | -4,808.36% |
| Jun 30, 2021 | -509.30% |
| Mar 31, 2021 | -366.95% |
| Dec 31, 2020 | -386.72% |
| Sep 30, 2020 | -215.00% |
| Jun 30, 2020 | -272.05% |
| Mar 31, 2020 | -174.90% |
| Dec 31, 2019 | -156.92% |
| Sep 30, 2019 | -102.49% |
| Jun 30, 2019 | -82.40% |
| Mar 31, 2019 | -76.95% |